Tinos Therapeutics, Inc.

Amendment
CIK: 0002088485·Biotechnology·DELAWARE·Filed: Apr 17, 2026
Total Offering

$4,000,000

Amount Sold

$2,250,000

Investors

3

First Sale

Sep 4, 2025

Offering Details

Type
Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
Nikolaos Tapinos
David Karambizi
Anastasios Polimenakos

Company

Tinos Therapeutics, Inc.

700 MAIN STREET

CAMBRIDGE, MA, 02139

570-939-7415

SEC Filing

0002088485-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Tinos Therapeutics, Inc. Form D Filing — $4,000,000 | FilingFlow